Navigation Links
Weight Loss Without Hunger!
Date:2/13/2009

Full Sense(TM) Device completes successful clinical evaluation

GRAND RAPIDS, Mich., Feb. 13 /PRNewswire/ -- Sentinel Group announced the completion of the first study of the Full Sense(TM) Device. The study was conducted at Galenia Hospital in Cancun, Mexico by American doctors Randal Baker MD, James Foote MD and Mexican doctor Jorge Trevino MD. The study protocol was designed to have the devices implanted for 6 weeks to evaluate weight loss, satiety (lack of hunger), safety, and removability.

The Full Sense(TM) Device is a stent like device placed through the mouth into the top of the stomach to cause satiety thus decreased hunger and increased fullness. It causes satiety by placing pressure on the bottom of the esophagus and the top of the stomach.

Patients not only lost significant weight in the study but also noted significant satiety with the device in place. Without the device they noted extreme hunger before meals whereas with the pressure from the Full Sense(TM) Device they experienced at most slight to no hunger before meals. The devices were removed safely and patients have stopped losing weight and are beginning to regain the weight that they had lost.

"The patients were extremely happy with the lack of hunger and resulting weight loss. They did not want the devices removed but reluctantly underwent removal per the protocol to demonstrate that the device could be easily removed," said Fred Walburn, PhD., President of Sentinel Group. "This technology represents potentially a new era of safe non-surgical weight loss treatment and offers hope for the millions of Americans who need treatment for obesity but can't afford the cost or possible complications of traditional weight loss surgery."

"Obesity is increasingly causing devastating effects on individuals and our society as a whole. This technology, I believe, offers the best opportunity yet to deliver consistent satiety and weight loss. Even many people with traditional weight loss surgery are experiencing significant hunger and subsequent weight regain. The potential to deliver satiety without classic incisions and surgery will give hope to many more people struggling with weight and weight related medical conditions," stated Randal Baker MD.

"The patients were very pleased with the results of the Full Sense(TM) Device," said Dr. Trevino, Head of Bariatric Surgery. "They are asking for the device to be implanted again!"

ABOUT GALENIA

The Galenia Hospital located in Cancun, Quintana Roo, Mexico is a modern facility with state of the art equipment which goes beyond the everyday services, with highly trained doctors and a wide range of medical specialties along with experienced people working for health care of national and international patients.

ABOUT SENTINEL GROUP

Sentinel Group is a medical device development company founded to commercialize patents owned by its principals and to assist physician inventors in commercializing their ideas. The company's intellectual property portfolio includes technologies in the areas of: bariatrics, colorectal anastomoses, diverticulitis, hiatal hernia, depression, Natural Orifice Translumenal Endoscopic Surgery (NOTES), Endoscopy and GERD. The Company's first product is the Full Sense(TM) Bariatric Device.

The Full Sense(TM) Device is not available in all markets pending regulatory clearance. Sentinel Group(R) and Full Sense(TM) Device are trademarks of Sentinel Group LLC.


'/>"/>
SOURCE Sentinel Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Losing Weight with Chocolate on Valentine's Day
2. Employee Weight Loss Programs Offered By Half of Employers Who Provide Wellness Programs
3. Losing weight can cure obstructive sleep apnea in overweight patients
4. How Much Weight Can They Lose in 90 Days?
5. ADA releases updated position statement on weight management
6. World Cancer Day Highlights Link Between Overweight and Cancer
7. Divorce, antidepressants, or weight gain/loss can add years to your face
8. Divorce, Antidepressants, or Weight Gain/Loss Can Add Years to Your Face
9. Growth hormone treatment after weight loss surgery prevents loss of muscle mass
10. Nutrition 21 Launches Breakthrough Weight Management Product: Iceland Health(R) Appetite Control Formula
11. Dallas – Fort Worth Bariatric Surgeon Dr. David Kim One of Few in America Selected to Perform New Weight Loss Surgery Procedure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... for physical disease or injury that focuses on repairing the musculoskeletal and neuromuscular ... With an emphasis on functional restoration, NYDNRehab began providing treatments for physical therapy ...
(Date:5/24/2016)... ... May 24, 2016 , ... Backed by decades of experience, ... job, ensuring the best suited solution to meet regulatory requirements. Their professional staff ... lab in Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... egg freezing, today announced the official relaunch of its community and education hub ... frozen eggs. Eggsurance's mission is to create a safe and welcoming place for ...
(Date:5/24/2016)... ... May 24, 2016 , ... The Radiosurgery Society ... of radiosurgery, is recognizing five medical residents and students for their outstanding contributions ... (SBRT). The awards will be presented at the 2016 SRS/SBRT Scientific Meeting taking ...
(Date:5/24/2016)... ... May 24, 2016 , ... The ... 9.3 million people, or 10% over last year, according to data in the ... group policies was comparatively stable, with a slight decrease in risk-based groups and ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... -- Experts from various countries ... role of technology in innovative healthcare ... International Conference of VPS-Penn Medicine opened in Abu ... Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Culture and ... provide personalized medicine and tailor-made healthcare in disease treatment and ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
(Date:5/20/2016)... , May 20, 2016 According ... driver is the increasing demand for affordable healthcare solutions as ... steadily on the rise. In countries like the US, the ... In the US, the consumer price index inflation rate stood ... inflation rate moved up to 3.62% during the same time ...
Breaking Medicine Technology: